Senate Committee: Why Can’t We Label Where Pharmaceuticals Come From?
✦ NabkaNews BriefAuto-summarized from multiple outlets · verify with the source
A senate committee is considering the issue of labeling the origin of pharmaceuticals. There are efforts to require country of origin labeling on prescription medications, with some legislation being proposed to address this issue. The status of these efforts is uncertain, with some bills dying in committee and others being unveiled or investigated.
Full coverage
1
Idaho Capital Sun·Mar 92
Rev·Apr 233
MedPage Today·Jan 304
MedShadow Foundation·Feb 55
ProPublica·Feb 66
The Hill·Jan 297
South Carolina Public Radio·Feb 248
Washington State Standard·Feb 10